William Curtis is WaveSense’s Chief Executive Officer and a member of WaveSense’s Board of Directors. Mr. Curtis joined WaveSense in July 2015 and brings over 30 years of experience in the healthcare industry. He has exclusively been involved in healthcare business development and healthcare services since 1983.
Prior to joining WaveSense, Mr. Curtis was the co-founder, Chairman and Chief Executive Officer of CBLPath Holdings Corporation, a specialized anatomic pathology and molecular laboratory that under his leadership experienced organic, profitable revenue growth from $4MM to $85+MM. Previously, he was the founder and Chief Executive Officer of MLC International and The Hillside Group, healthcare financial and business development companies.
Mr. Curtis majored in Philosophy at Providence College.
Richard S. Creager, Ph.D. is a recognized diagnostics new product development (NPD) and business leader who has a passion for building high performance global teams and using their expertise to deliver breakthrough products and build successful businesses. Richard has diverse experience developing new products, new technologies and new business models for diagnostic, laboratory services and B2B companies. He has developed new businesses that range from $25 million to more than $1 billion in annual sales. In addition, he managed large innovation teams and business units and has significant experience in developing market strategies, product and technology pipelines, portfolio management, licensing and development partnerships. Using his expertise in organizational design, talent management, product development, program management, and quality & design control systems, Richard works with companies to achieve the dexterity they require to get ahead of their competitors. Dr. Creager is the former chief science officer and executive officer for Beckman Coulter. He holds B.S. and M.S. degrees in biology and earned his Ph.D. degree in Microbiology at the University of Pittsburgh School of Medicine.
Steve Blanc is a strategic and tactical expert in leading sales teams and driving company growth. He has a proven track record producing revenue streams and operational enhancements in multiple sales, marketing and general management roles both domestic and international. His experience spans capital equipment, service and consumables sales to a broad range of customers: hospitals, government research institutes, reference labs, pharmaceutical and biotech companies.
Throughout a successful three-decade plus tenure, Steve consistently achieved unprecedented results in multiple sales, marketing and general management roles while successfully leading both domestic and international sales teams. He progressed to the highest level of executive sales responsibility within the multi billion-dollar life sciences diagnostic company, Beckman Coulter.
Bruce Irvine is a Director of Research and Development with over 30 years experience successfully supporting and managing multi-site and multi-disciplinary teams developing assays and platforms for Clinical Diagnostics. He is also a successful innovator with over 11 original patented inventions and has a track record of successfully designing and developing 510K cleared assays for infectious diseases and genetic disorders. His success is demonstrated through innovation, assay development, molecular biology, sample preparation technology, Business Development, system integration, regulatory compliance, project management, Six Sigma, winning and managing grants.
Tim Bruemmer is a serial entrepreneur who has also experienced extensive success in large public companies. Tim’s passion is innovation and he has founded numerous high-technology companies in a variety of markets with multiple successful exits. He is also an intrapreneur, having led both a global engineering development organization as well as a global science and engineering research and development organization. In those roles, Tim was responsible for the development and launch of dozens of new products in regulated and research markets leading to > $1B in cumulative revenue and often resulting in market leading positions. In addition, Tim has extensive experience driving value creation through acquisitions, leading technical due-diligence efforts and integrating both acquired product lines and entire businesses into companies he founded and as an executive within a Fortune 500 company. These experiences, plus his experiences creating and managing organizational structures for manufacturing operations, product development and quality systems, provide Tim with an intimate understanding of the impact of corporate structure and culture on innovation. Tim has a B.S. in Chemical Engineering from the University of California at Berkeley, started his career at Eastman Kodak and has spent 35 years building and optimizing innovative organizations. These experiences make Tim uniquely capable in both intrapreneurial and entrepreneurial environments.
Jai Murthy is a molecular biologist who has spent much of his career in strategic marketing roles for startups, mid-sized, and Fortune 100 companies helping to advance emerging life science technologies. Jai has 16 years of global experience developing, marketing, distributing, and selling life sciences products and services. He has successfully developed and executed market development strategies in over 50 countries, with specialization in the regulated markets of pharma manufacturing, medical devices, and diagnostics.
With a strong scientific background and broad business experiences, Jai offers a unique perspective into the technical and business challenges facing companies as they seek to expand their served markets vertically or into adjacent segments. Speaking multiple languages, Jai has extensive global expertise that includes the management of functional teams and completion of long-term projects across five continents. Jai holds a Ph.D. in Molecular and Cellular Biology from Harvard University.